Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...
Dave Jackson | December 17, 2020 |

Why XOM is close to an ideal option trading candidate

XOM has a hugely active options series, trades in both monthly and weekly expiration series and has bid / ask spreads that are just a few pennies wide. One of the most interesting aspects of options is the myriad opportunities presented for high probability trades for thos...
J.W. Jones | February 6, 2013 |

Why Provention Bio Is in My Portfolio

Quite often when I write about companies I'm just about the only one doing so. It's in these situations that Tailwinds can add value by not only highlighting our investment thesis, but in educating investors about a company for which there is little to no publicly avail...
Streetwise Reports | August 26, 2019 |

What Resource Companies Are on This Fund Manager's Buy List?

Ralph Aldis, portfolio manager at U.S. Global Investors, in this interview with Streetwise Reports, looks at precious metals during the global downturn, and discusses M&A in the industry as well as companies he sees as undervalued. Streetwise Reports: Ralph, tha...
Streetwise Reports | June 26, 2020 |

Buzz on the Bullboards: Will Cooler Heads Prevail?

The weather might be getting colder over the last few weeks, but the markets have been heating up. With lots of talk about the state of the global economy and increased political turmoil, it pays to focus on to how each sector is faring. Every week, the Stockhouse Bullboar...
Omri Wallach | October 2, 2019 |

Market News Report: April 6, 2020 - April 10, 2020

The economic data releases are starting to show coronavirus crisis impact on the economy. Last week’s Thursday’s Unemployment Claims number has reached almost 7 million! And we will likely get more bad economic data this week. Let&CloseCurl...
Paul Rejczak | April 6, 2020 |

Nov 27th 2019, Silver Chartbook: Risk less – trade more

Risk less – trade more Once a speculator has an established edge he/she has two ways of increasing profitability. Frequency = exposing the edge more often. Size = trade larger. It depends on ones psychology, ones system and many more factors to select one of those two rout...
Korbinian Koller | November 29, 2019 |

Repeating Patterns In Human Behavior

GREED AND FEAR The January 1987 edition of Military Review, a professional journal of the U.S. Army, noted: “Since the mind of the individual soldier has not changed and fear is the crucial factor in the outcome of all battles, tactics must be directed not just against...
Chris Ciovacco | December 23, 2019 |

Two Approvals Underscore Biotech's Pipeline Quality

The green lights and their implications are discussed in an H.C. Wainwright & Co. report. In a Jan. 22 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that the European Commission approved the regimen consisting of Genmab A/S' (GMAB:NASD...
Streetwise Reports | January 30, 2020 |

Coverage Resumed on Canadian Producer Following Acquisition

A review of the transaction and its implications are provided in a BMO Capital Markets report. In a Feb. 3 research note, analyst Brian Quast reported that BMO Capital Markers resumed coverage and lowered its target price on Kirkland Lake Gold Inc. (KL:TSX;...
Streetwise Reports | February 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...